Clinical trials
Vision Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 7 |
| 2021 | 5 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 6 |
| Unknown status | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| University Health Network, Toronto | 5 |
| Laboratoires Thea | 3 |
| ProQR Therapeutics | 3 |
| Unity Health Toronto | 3 |
| Bayer | 2 |
| McMaster University | 2 |
| Jaeb Center for Health Research | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| LumiThera, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vision Disorders | 33 |
| Retinal Diseases | 8 |
| Eye Diseases | 6 |
| Eye Abnormalities | 5 |
| Macular Degeneration | 5 |
| Macular Edema | 5 |
| Blindness | 4 |
| Eye Diseases, Hereditary | 4 |
| Retinal Vein Occlusion | 4 |
| Vision, Low | 4 |
Trials
Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.